1. MTA1‐activated Epi‐microRNA‐22 regulates E‐cadherin and prostate cancer invasiveness. Issue 6 (12th March 2017) Authors: Dhar, Swati; Kumar, Avinash; Gomez, Christian R.; Akhtar, Israh; Hancock, John C.; Lage, Janice M.; Pound, Charles R.; Levenson, Anait S. Journal: FEBS letters Issue: Volume 591:Issue 6(2017) Page Start: 924 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. GENE-06. THE ONCOHISTONE H3.3K27M DRIVES DIFFUSE INTRINSIC PONTINE GLIOMA INDEPENDENT OF FUNCTIONAL EZH2. (5th November 2018) Authors: Dhar, Swati; Becher, Oren Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 6 Page Start: vi103 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. DIPG-44. A GAIN OF FUNCTION Ezh2 MUTATION DELAYS DIFFUSE INTRINSIC PONTINE GLIOMA PROGRESSION. (4th December 2020) Authors: Dhar, Swati; Gadd, Samantha; Brat, Daniel; Becher, Oren Journal: Neuro-oncology Issue: Volume 22(2020)Supplement 3 Page Start: iii295 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Epigenetic potential of resveratrol and analogs in preclinical models of prostate cancer. (27th July 2015) Authors: Kumar, Avinash; Dhar, Swati; Rimando, Agnes M.; Lage, Janice M.; Lewin, Jack R.; Zhang, Xu; Levenson, Anait S. Other Names: Vang Ole guestEditor.; Pezzuto John M. guestEditor. Journal: Annals of the New York Academy of Sciences Issue: Volume 1348(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. MTA1 drives malignant progression and bone metastasis in prostate cancer. Issue 9 (14th August 2018) Authors: Kumar, Avinash; Dhar, Swati; Campanelli, Gisella; Butt, Nasir A.; Schallheim, Jason M.; Gomez, Christian R.; Levenson, Anait S. Journal: Molecular oncology Issue: Volume 12:Issue 9(2018) Page Start: 1596 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Targeting MTA1/HIF‐1α signaling by pterostilbene in combination with histone deacetylase inhibitor attenuates prostate cancer progression. (10th October 2017) Authors: Butt, Nasir A.; Kumar, Avinash; Dhar, Swati; Rimando, Agnes M.; Akhtar, Israh; Hancock, John C.; Lage, Janice M.; Pound, Charles R.; Lewin, Jack R.; Gomez, Christian R.; Levenson, Anait S. Journal: Cancer medicine Issue: Volume 6:Number 11(2017:Nov.) Page Start: 2673 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Trimethoxy‐Resveratrol and Piceatannol Administered Orally Suppress and Inhibit Tumor Formation and Growth in Prostate Cancer Xenografts. Issue 11 (8th May 2013) Authors: Dias, Steven J.; Li, Kun; Rimando, Agnes M.; Dhar, Swati; Mizuno, Cassia S.; Penman, Alan D.; Levenson, Anait S. Journal: Prostate Issue: Volume 73:Issue 11(2013) Page Start: 1135 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗